维普中文期刊产品整合服务
69篇 您的检索式:作者名="DRAGOVICH T"
    题名 作者 年代 出处 被引量
1Phase Ⅱ trial of erlotinib in gastroesopha-geal junction and gastric adenocarcinomas:SWOG0127显示文摘Dragovich T McCoy S Fenoglio-Preiser CM 2006J Clin Oncol2006,24,30:1
2Phase Ⅱ trial of erlotinib in gastroesophageal junction and gastric adenocarcinoma:SWOG 0127显示文摘Dragovich T McCoy S Feniglio-Preiser CM 2006J Clin Oncol2006,24,:1
3A phase Ⅱ trial of celecoxib,irinotecan,5-fluorouraciland leucovorin in patients with unresectable or metastatic colorectal cancer显示文摘Blanke CD Benson A Dragovich T 2002Proc Am Soc Clin Oncol2002,2,4:1
4Management strategies in pan-creatic caneer显示文摘Campen CJ Dragovich T Baker AF 2011Am J Health Syst Pharm2011,68,7:1
5The antitumor thioredoxin-linhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma显示文摘Baker A F Dragovich T Tate W R 2006Lab Clin Med2006,147,:1
6A phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer显示文摘Dragovich T Mendelson D Kurtin S 2006Cancer Chemother Pharmacol2006,58,6:1
7A phase Ⅱ trial of celecoxib,irinotecan,5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal cancer显示文摘Blanke CD Benson AB Dragovich T 2002Proc Am Soc Clin Oncol2002,21,:1
8Management strate- gies in pancreatic cancer显示文摘CAMPEN C J DRAGOVICH T BAKER AF 2011Am J Health Syst Pharm2011,68,7:1
9A randomizedphase II study of PX - 12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcit- abine - containing combination 显示文摘Ramanathan R K Abbruzzese J Dragovich T 2011Cancer Chemother Pharmacol2011,67,3:1
10A phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer 显示文摘DRAGOVICH T MENDELSON D KURTIN S 2006Cancer Chemother Pharraacol2006,58,6:1
11Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127显示文摘Dragovich T McCoy S Fenoglio-Preiser CM 2006J Clin Oncol2006,24,:1
12A phase Ⅱ trial of celecoxib, erinotecan,5-fluorouracil and leucovofin in patients with unresectable or metastatic colorectal cancer显示文摘Blanke CD Benson A Dragovich T 2002Proc Am Soc Clin Oncol2002,21,4:1
13PhaseⅡtrial of erlotinib in gastroesophageal junction and gasric adenocarcinomas:SWOG 0127显示文摘Dragovich T Mc Coy S Fenoglio-Preiser CM 2006J Clin Oncol2006,24,30:1
14A phase Ⅱ trial of eelecoxib, irinotecan, 5-fluorouracil and leucovorin in patients with unreseetable or metastatic colorectal cancer 显示文摘Blanke CD Benson AB Dragovich T 2002Proe Am Soc Clin Oneol2002,21,:1
15A phase 2 trial of the liposomal DACH platinum L- NDDP in patients with therapy- refractory advanced coloreetal cancer显示文摘Dragovich T Mendelson D Kurtin S 2006Cancer Chemother Pharmacol2006,58,6:1
16Phase II trial of erlotinib in gastroesophageal junction and gastric adenocar- cinomas: SWOG 0127显示文摘Dragovich T McCoy S Fenoglio-Preiser CM 2006J Clin Oncol2006,24,30:1
17Phase II trial oferlotinib in gastroesophageal junction and gastric adenocarcinomas:SWOG 0127 显示文摘Dragovich T McCoy S Fenoglio-Preiser CM 2006J Clin Oncol2006,24,30:1
18A phase Ⅱ trial of celecoxib, irinotecan, 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal cancer显示文摘Blanke CD Benson A Dragovich T 2002Proc Am Soc Clin Oncol2002,21,4:1
19Arandomized phase II study of PX - 12, an inhibitor of thi-oredoxin in patients with advanced cancer of the pancreasfollowing progression after a gemcitabine - containing com-bination 显示文摘Ramanathan RK Abbruzzese J Dragovich T 2011Cancer Chemother Pharmacol2011,67,3:1
20Phase Ⅱ trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127 显示文摘Dragovich T McCoy S Fenoglio-Preiser CM 2006J Clin Oncol2006,24,30:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费